ID   S38A2_HUMAN             Reviewed;         506 AA.
AC   Q96QD8; Q6IA88; Q6ZMG2; Q9HAV3; Q9NVA8; Q9P2G5;
DT   04-DEC-2007, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 2.
DT   10-MAY-2017, entry version 129.
DE   RecName: Full=Sodium-coupled neutral amino acid transporter 2;
DE   AltName: Full=Amino acid transporter A2;
DE   AltName: Full=Protein 40-9-1;
DE   AltName: Full=Solute carrier family 38 member 2;
DE   AltName: Full=System A amino acid transporter 2;
DE   AltName: Full=System A transporter 1;
DE   AltName: Full=System N amino acid transporter 2;
GN   Name=SLC38A2; Synonyms=ATA2, KIAA1382, SAT2, SNAT2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, ENZYME REGULATION,
RP   AND TISSUE SPECIFICITY.
RC   TISSUE=Hepatoma;
RX   PubMed=10930503; DOI=10.1016/S0005-2736(00)00252-2;
RA   Hatanaka T., Huang W., Wang H., Sugawara M., Prasad P.D.,
RA   Leibach F.H., Ganapathy V.;
RT   "Primary structure, functional characteristics and tissue expression
RT   pattern of human ATA2, a subtype of amino acid transport system A.";
RL   Biochim. Biophys. Acta 1467:1-6(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Powell J., Brock A.P., Hart I.R.;
RT   "Expression studies of the human amino acid transporter, hATA2.";
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Schmidt T.;
RL   Thesis (2001), University of Goettingen, Germany.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10718198; DOI=10.1093/dnares/7.1.65;
RA   Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVI.
RT   The complete sequences of 150 new cDNA clones from brain which code
RT   for large proteins in vitro.";
RL   DNA Res. 7:65-73(2000).
RN   [5]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Hepatoma, and Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   INDUCTION.
RX   PubMed=14623874; DOI=10.1074/jbc.M310483200;
RA   Palii S.S., Chen H., Kilberg M.S.;
RT   "Transcriptional control of the human sodium-coupled neutral amino
RT   acid transporter system A gene by amino acid availability is mediated
RT   by an intronic element.";
RL   J. Biol. Chem. 279:3463-3471(2004).
RN   [11]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=15922329; DOI=10.1016/j.febslet.2005.05.002;
RA   Bevilacqua E., Bussolati O., Dall'Asta V., Gaccioli F., Sala R.,
RA   Gazzola G.C., Franchi-Gazzola R.;
RT   "SNAT2 silencing prevents the osmotic induction of transport system A
RT   and hinders cell recovery from hypertonic stress.";
RL   FEBS Lett. 579:3376-3380(2005).
RN   [12]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15561425; DOI=10.1016/j.neuroscience.2004.09.023;
RA   Gonzalez-Gonzalez I.M., Cubelos B., Gimenez C., Zafra F.;
RT   "Immunohistochemical localization of the amino acid transporter SNAT2
RT   in the rat brain.";
RL   Neuroscience 130:61-73(2005).
RN   [13]
RP   INDUCTION.
RX   PubMed=16621798; DOI=10.1074/jbc.M600341200;
RA   Gaccioli F., Huang C.C., Wang C., Bevilacqua E., Franchi-Gazzola R.,
RA   Gazzola G.C., Bussolati O., Snider M.D., Hatzoglou M.;
RT   "Amino acid starvation induces the SNAT2 neutral amino acid
RT   transporter by a mechanism that involves eukaryotic initiation factor
RT   2alpha phosphorylation and cap-independent translation.";
RL   J. Biol. Chem. 281:17929-17940(2006).
RN   [14]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=16616430; DOI=10.1016/j.neuroscience.2006.02.042;
RA   Melone M., Varoqui H., Erickson J.D., Conti F.;
RT   "Localization of the Na(+)-coupled neutral amino acid transporter 2 in
RT   the cerebral cortex.";
RL   Neuroscience 140:281-292(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10 AND SER-12, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-55, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Functions as a sodium-dependent amino acid transporter.
CC       Mediates the saturable, pH-sensitive and electrogenic cotransport
CC       of neutral amino acids and sodium ions with a stoichiometry of
CC       1:1. May function in the transport of amino acids at the blood-
CC       brain barrier and in the supply of maternal nutrients to the fetus
CC       through the placenta. {ECO:0000269|PubMed:10930503,
CC       ECO:0000269|PubMed:15922329}.
CC   -!- ENZYME REGULATION: Inhibited by N-methyl-D-glucamine and probably
CC       choline. {ECO:0000269|PubMed:10930503}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.39 mM for 2-methylamino-isobutyric acid (MeAIB) (at pH
CC         8.0);
CC   -!- INTERACTION:
CC       Q99942:RNF5; NbExp=3; IntAct=EBI-723083, EBI-348482;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15561425,
CC       ECO:0000269|PubMed:16616430}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:15561425, ECO:0000269|PubMed:16616430}.
CC       Note=Insulin promotes recruitment to the plasma membrane from a
CC       pool localized in the trans-Golgi network or endosomes (By
CC       similarity). Enriched in the somatodendritic compartment of
CC       neurons, it is also detected at the axonal shaft but excluded from
CC       the nerve terminal. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96QD8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96QD8-2; Sequence=VSP_029553, VSP_029554;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Widely expressed in
CC       the central nervous system with higher concentrations in caudal
CC       regions. Expressed by glutamatergic and GABAergic neurons together
CC       with astrocytes and other non-neuronal cells in the cerebral
CC       cortex (at protein level). {ECO:0000269|PubMed:10930503,
CC       ECO:0000269|PubMed:15561425, ECO:0000269|PubMed:16616430}.
CC   -!- INDUCTION: Up-regulated upon hypertonic conditions and amino acid
CC       deprivation. {ECO:0000269|PubMed:14623874,
CC       ECO:0000269|PubMed:15922329, ECO:0000269|PubMed:16621798}.
CC   -!- PTM: Polyubiquitination by NEDD4L regulates the degradation and
CC       the activity of SLC38A2. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Depletion of SCL38A2 by siRNA prevents the recovery
CC       of cells from hypertonic stress.
CC   -!- SIMILARITY: Belongs to the amino acid/polyamine transporter 2
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAD18765.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF259799; AAK38510.1; -; mRNA.
DR   EMBL; AF298897; AAG24618.1; -; mRNA.
DR   EMBL; AJ344099; CAC51434.1; -; mRNA.
DR   EMBL; AB037803; BAA92620.2; -; mRNA.
DR   EMBL; AK001700; BAA91846.1; -; mRNA.
DR   EMBL; AK172784; BAD18765.1; ALT_INIT; mRNA.
DR   EMBL; CR457267; CAG33548.1; -; mRNA.
DR   EMBL; CH471111; EAW57900.1; -; Genomic_DNA.
DR   EMBL; CH471111; EAW57901.1; -; Genomic_DNA.
DR   EMBL; BC040342; AAH40342.1; -; mRNA.
DR   CCDS; CCDS76551.1; -. [Q96QD8-2]
DR   CCDS; CCDS8749.1; -. [Q96QD8-1]
DR   RefSeq; NP_001294865.1; NM_001307936.1. [Q96QD8-2]
DR   RefSeq; NP_061849.2; NM_018976.4. [Q96QD8-1]
DR   UniGene; Hs.221847; -.
DR   ProteinModelPortal; Q96QD8; -.
DR   BioGrid; 119943; 26.
DR   IntAct; Q96QD8; 26.
DR   MINT; MINT-1398587; -.
DR   STRING; 9606.ENSP00000256689; -.
DR   TCDB; 2.A.18.6.5; the amino acid/auxin permease (aaap) family.
DR   iPTMnet; Q96QD8; -.
DR   PhosphoSitePlus; Q96QD8; -.
DR   SwissPalm; Q96QD8; -.
DR   BioMuta; 2/14/2002; -.
DR   DMDM; 162416227; -.
DR   EPD; Q96QD8; -.
DR   MaxQB; Q96QD8; -.
DR   PaxDb; Q96QD8; -.
DR   PeptideAtlas; Q96QD8; -.
DR   PRIDE; Q96QD8; -.
DR   DNASU; 54407; -.
DR   Ensembl; ENST00000256689; ENSP00000256689; ENSG00000134294. [Q96QD8-1]
DR   Ensembl; ENST00000612232; ENSP00000482873; ENSG00000134294. [Q96QD8-2]
DR   GeneID; 54407; -.
DR   KEGG; hsa:54407; -.
DR   UCSC; uc001rpg.4; human. [Q96QD8-1]
DR   CTD; 54407; -.
DR   DisGeNET; 54407; -.
DR   GeneCards; SLC38A2; -.
DR   HGNC; HGNC:13448; SLC38A2.
DR   HPA; HPA035180; -.
DR   MIM; 605180; gene.
DR   neXtProt; NX_Q96QD8; -.
DR   OpenTargets; ENSG00000134294; -.
DR   PharmGKB; PA37773; -.
DR   eggNOG; KOG1305; Eukaryota.
DR   eggNOG; COG0814; LUCA.
DR   GeneTree; ENSGT00760000119147; -.
DR   HOGENOM; HOG000013088; -.
DR   HOVERGEN; HBG059571; -.
DR   InParanoid; Q96QD8; -.
DR   KO; K14207; -.
DR   OMA; ITHLLCA; -.
DR   OrthoDB; EOG091G0GP8; -.
DR   PhylomeDB; Q96QD8; -.
DR   TreeFam; TF328787; -.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-352230; Amino acid transport across the plasma membrane.
DR   ChiTaRS; SLC38A2; human.
DR   GeneWiki; SLC38A2; -.
DR   GenomeRNAi; 54407; -.
DR   PRO; PR:Q96QD8; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000134294; -.
DR   CleanEx; HS_SAT2; -.
DR   CleanEx; HS_SLC38A2; -.
DR   ExpressionAtlas; Q96QD8; baseline and differential.
DR   Genevisible; Q96QD8; HS.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005887; C:integral component of plasma membrane; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0042383; C:sarcolemma; IEA:Ensembl.
DR   GO; GO:0015171; F:amino acid transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0032328; P:alanine transport; IEA:Ensembl.
DR   GO; GO:0003333; P:amino acid transmembrane transport; IBA:GO_Central.
DR   GO; GO:0006865; P:amino acid transport; TAS:Reactome.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IEA:Ensembl.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0007565; P:female pregnancy; IEA:Ensembl.
DR   GO; GO:0014047; P:glutamate secretion; TAS:Reactome.
DR   GO; GO:0031460; P:glycine betaine transport; IEA:Ensembl.
DR   GO; GO:0006814; P:sodium ion transport; IEA:UniProtKB-KW.
DR   InterPro; IPR013057; AA_transpt_TM.
DR   Pfam; PF01490; Aa_trans; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Amino-acid transport; Cell membrane;
KW   Complete proteome; Glycoprotein; Ion transport; Membrane;
KW   Phosphoprotein; Polymorphism; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport; Ubl conjugation.
FT   CHAIN         1    506       Sodium-coupled neutral amino acid
FT                                transporter 2.
FT                                /FTId=PRO_0000311369.
FT   TOPO_DOM      1     76       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     77     97       Helical. {ECO:0000255}.
FT   TOPO_DOM     98    102       Extracellular. {ECO:0000255}.
FT   TRANSMEM    103    123       Helical. {ECO:0000255}.
FT   TOPO_DOM    124    158       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    159    179       Helical. {ECO:0000255}.
FT   TOPO_DOM    180    188       Extracellular. {ECO:0000255}.
FT   TRANSMEM    189    209       Helical. {ECO:0000255}.
FT   TOPO_DOM    210    217       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    218    238       Helical. {ECO:0000255}.
FT   TOPO_DOM    239    292       Extracellular. {ECO:0000255}.
FT   TRANSMEM    293    313       Helical. {ECO:0000255}.
FT   TOPO_DOM    314    329       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    330    350       Helical. {ECO:0000255}.
FT   TOPO_DOM    351    371       Extracellular. {ECO:0000255}.
FT   TRANSMEM    372    392       Helical. {ECO:0000255}.
FT   TOPO_DOM    393    413       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    414    434       Helical. {ECO:0000255}.
FT   TOPO_DOM    435    436       Extracellular. {ECO:0000255}.
FT   TRANSMEM    437    457       Helical. {ECO:0000255}.
FT   TOPO_DOM    458    474       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    475    495       Helical. {ECO:0000255}.
FT   TOPO_DOM    496    506       Extracellular. {ECO:0000255}.
FT   REGION        1     96       Regulates protein turnover upon amino
FT                                acid deprivation. {ECO:0000250}.
FT   MOD_RES      10     10       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      12     12       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES      21     21       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8CFE6}.
FT   MOD_RES      22     22       Phosphoserine.
FT                                {ECO:0000244|PubMed:19690332}.
FT   MOD_RES      55     55       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CARBOHYD    258    258       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    274    274       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ       1    100       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_029553.
FT   VAR_SEQ     101    105       IALFI -> MKQNL (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|Ref.7}.
FT                                /FTId=VSP_029554.
FT   VARIANT      48     48       N -> K (in dbSNP:rs11183450).
FT                                /FTId=VAR_037235.
FT   CONFLICT    156    156       M -> V (in Ref. 3; CAC51434).
FT                                {ECO:0000305}.
FT   CONFLICT    273    273       H -> R (in Ref. 6; BAA91846).
FT                                {ECO:0000305}.
SQ   SEQUENCE   506 AA;  56026 MW;  125C70875793D031 CRC64;
     MKKAEMGRFS ISPDEDSSSY SSNSDFNYSY PTKQAALKSH YADVDPENQN FLLESNLGKK
     KYETEFHPGT TSFGMSVFNL SNAIVGSGIL GLSYAMANTG IALFIILLTF VSIFSLYSVH
     LLLKTANEGG SLLYEQLGYK AFGLVGKLAA SGSITMQNIG AMSSYLFIVK YELPLVIQAL
     TNIEDKTGLW YLNGNYLVLL VSLVVILPLS LFRNLGYLGY TSGLSLLCMV FFLIVVICKK
     FQVPCPVEAA LIINETINTT LTQPTALVPA LSHNVTENDS CRPHYFIFNS QTVYAVPILI
     FSFVCHPAVL PIYEELKDRS RRRMMNVSKI SFFAMFLMYL LAALFGYLTF YEHVESELLH
     TYSSILGTDI LLLIVRLAVL MAVTLTVPVV IFPIRSSVTH LLCASKDFSW WRHSLITVSI
     LAFTNLLVIF VPTIRDIFGF IGASAASMLI FILPSAFYIK LVKKEPMKSV QKIGALFFLL
     SGVLVMTGSM ALIVLDWVHN APGGGH
//
